SPIE BIOS | 19-24 JANUARY 2008
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XVII
Editor(s): David Kessel

9 Sessions, 20 Papers, 0 Presentations
Front Matter  (1)
Dosimetry  (1)
Proceedings Volume 6845 is from: Logo
19-24 January 2008
San Jose, California, United States
Front Matter
Proc. SPIE 6845, Front Matter: Volume 6845, 684501 (28 February 2008);
Preclinical I
Proc. SPIE 6845, Promotion of PDT efficacy by HA14-1, 684502 (8 February 2008);
Preclinical II
Proc. SPIE 6845, Lysosome vs. mitochondrion as photosensitizer binding site: how does the tortoise overtake the hare?, 684505 (11 February 2008);
Proc. SPIE 6845, Contribution of mitochondria and lysosomes to photodynamic therapy-induced death in cancer cells, 684506 (25 February 2008);
Proc. SPIE 6845, Protein oxidation by the phthalocyanine photosensitizer Pc 4 and light: detection of a unique singlet oxygen-generated product in cytochrome c, 684507 (11 February 2008);
Proc. SPIE 6845, Interstitial diffuse optical tomography using an adjoint model with linear sources, 68450C (11 February 2008);
Preclinical III
Proc. SPIE 6845, Noninvasive murine glioma detection improved following photobleaching of skin PpIX fluorescence, 68450D (25 February 2008);
Clinical Studies
Proc. SPIE 6845, Preliminary study of transurethral photodynamic therapy mediated with Tookad in a canine prostate model, 68450J (25 February 2008);
Proc. SPIE 6845, Linear feasibility algorithms for treatment planning in interstitial photodynamic therapy, 68450O (27 February 2008);
Proc. SPIE 6845, Sensitivity analysis of imaging geometries for prostate diffuse optical tomography, 68450P (18 February 2008);
Proc. SPIE 6845, Integrated light dosimetry system for prostate photodynamic therapy, 68450Q (19 February 2008);
New Sensitizers
Proc. SPIE 6845, Synthesis, characterization and two-photon PDT efficacy studies of triads incorporating tumor targeting and imaging components, 68450S (11 February 2008);
Proc. SPIE 6845, Time-resolved luminescence measurements of the magnetic field effect on paramagnetic photosensitizers in photodynamic reactions, 68450T (11 February 2008);
Proc. SPIE 6845, Histopathological and expression profiling studies of early tumor responses to near-infrared PDT treatment in SCID mice, 68450U (11 February 2008);
Poster Session
Proc. SPIE 6845, Photodynamic therapy (PDT) to treat a chronic skin wound in a dog, 68450X (11 February 2008);
Proc. SPIE 6845, The role of autofluorescence diagnostics in the diseases of oral mucosa, 68450Y (11 February 2008);
Proc. SPIE 6845, The difference of the PDT's effects between interstitial lighting and continuous lighting in low oxygen density, 684510 (12 February 2008);
Proc. SPIE 6845, In silico analysis of quantifying tumor hemoglobin saturation using the optical pharmacokinetic system (OPS), 684512 (12 February 2008);
Proc. SPIE 6845, Fluorescence quantum yield of verteporfin is independent of oxygen, 684517 (27 February 2008);
Proc. SPIE 6845, Dosimetric considerations of interstitial photodynamic therapy of the canine prostate mediated by intra-arterially administered hypocrellin derivative, 684519 (11 February 2008);
Back to Top